Why Is Horizon Therapeutics (HZNP) Up 38.3% Since Last Earnings Report?Zacks Investment Research • 12/02/22
Horizon's stock jumps 32% as the company confirms takeover interest from pharma giantsMarket Watch • 11/30/22
Horizon Therapeutics Surges on Takeover Talk. It Could Be 2022's Largest Healthcare Deal.Barrons • 11/30/22
Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, SanofiInvestors Business Daily • 11/29/22
Horizon Therapeutics plc Confirms Preliminary Discussions Regarding Potential OfferBusiness Wire • 11/29/22
New Research Partnership With Horizon Therapeutics Could Be the Next Revenue Catalyst for Xeris24/7 Wall Street • 11/29/22
Horizon Therapeutics (HZNP) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research • 11/23/22
Xeris Biopharma inks research collaboration and option agreement with Horizon TherapeuticsProactive Investors • 11/23/22
Xeris Biopharma Announces Research Collaboration and Option Agreement With Horizon Therapeutics plc for XeriJect™ Formulation of TeprotumumabBusiness Wire • 11/23/22
Horizon Therapeutics plc Announces Completion of Enrollment of Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating TEPEZZA® (teprotumumab-trbw) for the Treatment of Active Thyroid Eye Disease (TED)Business Wire • 11/16/22
Horizon Therapeutics plc Announces Scientific Collaboration with Leading Research Institution to Advance Research in Autoimmunity and InflammationBusiness Wire • 11/16/22
Horizon Therapeutics plc to Participate in Upcoming Investor Healthcare Conferences in NovemberBusiness Wire • 11/10/22
Sustained Patient Response to KRYSTEXXA® (pegloticase) Injection with Methotrexate Compared to KRYSTEXXA Alone Shown through Month 12 in MIRROR Randomized Controlled TrialBusiness Wire • 11/08/22
Data Support the Use of KRYSTEXXA® (pegloticase) Injection with Methotrexate to Treat Uncontrolled Gout in People With Mild-to-Moderate Chronic Kidney DiseaseBusiness Wire • 11/05/22
Horizon Therapeutics Public Limited Company (HZNP) Q3 2022 Earnings Call TranscriptSeeking Alpha • 11/02/22
Horizon Therapeutics (HZNP) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 11/02/22